The term artificial intelligence (AI) describes how computers, particularly computer systems, may simulate processes involving human intelligence. These processes include learning—acquiring knowledge and applying rules to apply it—reasoning—applying rules to draw inferences or resolve issues—and self-correction. Artificial intelligence (AI) technologies allow robots to do activities like interpreting natural language, identifying patterns, making decisions, as well as learning from experience that normally need human intelligence. Healthcare professionals, politicians, and academics must work together to create strong frameworks that guarantee the ethical and responsible use of AI as the pharmaceutical industry experiences a paradigm shift toward increased integration of this technology. The paper concludes by outlining future prospects and potential challenges, emphasizing the need for ongoing dialogue and collaboration to maximize the benefits of AI in advancing pharmacy practices and ultimately improving patient outcomes.